key: cord-0817654-uzt3yajr authors: Figueiredo Deana, Naira; Zaror, Carlos; Seiffert, Andrea; Aravena-Rivas, Yanela; Muñoz-Millán, Patricia; Espinoza-Espinoza, Gerardo; Pineda, Patricia; Alonso-Coello, Pablo title: QUALITY APPRAISAL OF CLINICAL PRACTICE GUIDELINES ON PROVISION OF DENTAL SERVICES DURING THE FIRST MONTHS OF THE COVID-19 PANDEMIC date: 2021-08-28 journal: J Evid Based Dent Pract DOI: 10.1016/j.jebdp.2021.101633 sha: 951d91123d13f68b334558d5d9640116cd8bf7a8 doc_id: 817654 cord_uid: uzt3yajr OBJECTIVES: To evaluate the quality of clinical practice guidelines (CPGs) on dental services provision during the first months of the COVID-19 pandemic. MATERIALS AND METHODS: We systematically searched in MEDLINE, EMBASE, LILACS, Epistemonikos, Trip databases, websites of CPG developers, compilers of CPGs, scientific societies and ministries of health to identify documents with recommendations intended to minimize the risk of COVID-19 transmission during dental care. Reviewers independently and in duplicate assessed the included CPGs using the AGREE II instrument. We calculated the standardized scores for the six domains and made a final recommendation about each CPG. The inter-appraiser agreement was assessed using the intraclass correlation coefficient (ICC). RESULTS: Twenty-three CPGs published were included. Most of the CPGs were from America (n=15) and Europe (n=6). The overall agreement between reviewers was very good (ICC = 0.93; 95%CI 0.87–0.95). The median score for each domain was the following: Scope and purpose 67% (IQR 20%); Stakeholder involvement 33% (IQR 14%); Rigour of development 13% (IQR 13%); Clarity of presentation 64% (IQR 31%); Applicability 19% (IQR 17%) and Editorial independence 8% (IQR 8%). Twenty two guidelines were not recommended by the reviewers. Only one of the CPGs was recommended with modifications. The median overall rate was 3 (IQR 1). All CPGs were classified as low quality. CONCLUSIONS: The overall quality of CPGs on dental services provision during the first months of the COVID-19 pandemic was low, which makes its implementation difficult for clinicians and policy makers. Therefore, it is critical that developers are transparent and forthcoming about the difficulties that have arisen during the CPG development process. By the end of 2019, the new Severe Acute Respiratory Syndrome CoronaVirus2 (SARS-CoV-2) was reported in Wuhan China. 1 This pathogen is the cause of the coronavirus 2019 disease . 2 In just a few months, COVID-19 had spread worldwide, becoming a major public health problem and being categorised by The World Health Organisation as a pandemic disease. 3 Epidemiological data shows that all ages are susceptible to COVID-19. However, individuals with co-morbidities are more likely to develop severe clinical symptoms. 4 Health workers are exposed to contaminated fluids / aerosols through close contact with SARS-CoV-2 infected patients face, having an unprecedented occupational risk of morbidity and mortality. 5, 6 In the field of dentistry, treatments are delivered in close proximity to the patient. Furthermore, dental workers are subject to frequent exposure to saliva, blood and other bodily fluids, 7 contact with contaminated surfaces, 7, 8 and frequent exposure to bioaerosols. 7, 9, 10 Dentists are at a higher risk of infection, and of becoming potential carriers of the disease. 9, 11 The use of the dental drill, ultrasonic scalers, and air/water syringes magnify the dissemination of saliva droplets, blood and aerosol emissions, all facilitate environment, equipment, and surface contamination. 12 As a result, dental service providers may also be at a higher risk of cross infection with patients. 9, 11 Currently, vaccines are being tested globally, nevertheless, it will take time until the majority of the population is protected. Meanwhile, biosafety measures are fundamental to stop the spread and transmission of the disease. Therefore, dental services must prioritize the patient's protection and reduce the coronavirus transmission risk, in both public and private dental services, to ensure the health and safety of the dental staff and patients. To provide appropriate dental services, protocols and clinical practice guidelines (CPGs) focused on important biosafety measures for a low-risk COVID-19 transmission environment have been developed. In order to provide the safest dental practice based on scientific evidence, CPGs should aim for the best quality and be readily available, 13 thus improving the quality and results of medical services. 14 Consequently, assessing the quality of CPGs developed during COVID-19 pandemic in the dental field is a critical task. In this study we assessed the quality of CPGs on dental services during the first months of the COVID-19 pandemic. Systematic evaluation of CPGs. For the development of this assessment we adhered to the Preferred Reporting Items of Systematic Reviews and Meta-Analysis PRISMA tool. 15 We published the protocol in Open Science Framework. 16 We included documents in English, Spanish and Portuguese self-declared as a guideline, guidance providing recommendations for walk-in or emergency dental care in the context of the COVID-19 pandemic. A document was also eligible if it was developed by regional, national, or local organizations, a team of experts, by a panel of experts, or if it provided a list of authors/experts involved in the process. We excluded Clinical Practice Guidelines developed exclusively for special-care patients, guidelines developed outside of the pandemic context, previous versions of the same guideline, letters to the editor, and conference summaries. We searched in MEDLINE, EMBASE, LILACS, Epistemonikos and Trip databases up to August 10, 2020. This was complemented by a manual search of guideline developers' websites, repositories, international dental scientific societies, Ministries of Health worldwide and institutions related to COVID-19 management. This search was also updated in August, 2020. (Appendix S1). We also examined the reference lists of the selected CPGs to identify other guidelines that met the inclusion criteria. We did not limit the search by date, language or publication status. The search strategy and databases used are listed in supplementary material (Appendix S1). All references identified were extracted to an EndNote X9 database to facilitate their management. Titles, abstracts and full texts were independently reviewed by two investigators (C.Z, G.E.E., N.F.D., P.M.M, P.P or Y.A.R) in a three-step process. We resolved disagreements with the help of a third reviewer. In the case of several documents from a single source, we included the most recent. One reviewer (C.Z, G.E.E, N.F.D., P.M.M, P.P or Y.A.R) extracted the data and another reviewer checked all the extracted information for accuracy. We extracted the following information from each article using a previously piloted data collection form: author, year, title, country, organization, language, setting, and target population. Applicability, shows the barriers and facilitators for the implementation of the CPG, also considering the financial implications to implement the recommendations; and 6. Editorial Independence, illustrating the transparency in the formulation of the guideline recommendations. Each of the 23 items is rated from 1 to 7 points in the Likert scale. The AGREE II instrument also includes two overall quality appraisals for each CPG: an overall score of 1 to 7, and whether the reviewer would recommend using the CPG, assessing it as recommended, recommended with modifications, or not recommended. 17 The total AGREE II score was calculated by summing up the individual items included in a domain and by scaling the total as a percentage of the maximum possible score for that domain. 17 If discrepancies between reviewers were higher than 3 points, or if the standard deviation (SD) in an item was greater than, or equal to 1.5 SD, the item of the guideline was reassessed by the reviewers and agreement was reached. 18 The reviewers considered the overall quality of the CPGs and made a final recommendation about each guideline. 18 We classified the CPG as high quality when at least three of the domains showed a score of 60% or higher, including the rigour of development domain. [17] [18] [19] The intraclass coefficient with its 95% confidence interval (95% CI) as an indicator of overall agreement between reviewers for each of the 23 After excluding duplicates, the search initially yielded 1149 references. Twelve documents were selected from databases and 11 were identified through other sources. Finally, 23 documents were included. Figure 1 shows the selection process flow chart. The agreement between reviewers during all phases of the process was high (Kappa=0.872). Of the CPGs included in the study, fifteen were from America, six from Europe and one from Asia and Oceania. The developers were mainly Ministries or Health Departments and government agencies (n= 11), scientific societies and dental colleges (n=13). Following publication of an initial version a total of 10 CPGs were subsequently updated. Main CPG characteristics are listed in Table 1 . The overall agreement between the two reviewers with respect to the use of the AGREE II instrument was very good (ICC = 0.93; 95%CI 0.7-0.95). Table 2 shows the standardized domain scores per CPG, as well as the overall recommendation. Of the six domains, three scored above 60% in at least one CPG: Scope and purpose in 16 CPGs (69.6%), [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Clarity of presentation in 15 CPGs (65.2%), [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [35] [36] [37] and Stakeholder involvement in two CPGs (8.7%). 27, 28 The domain with the highest score was Scope and Purpose (median 67.0%), and the one with the lowest score was Editorial Independence (median 8.0%). The median score was 67.0% (IQR 20.0%). Of the 23 guidelines, 16 (69.6%) 23 None of the 22 assessed guidelines was recommended by the reviewers. Only one of the CPGs (4.3%) 27 was recommended with modifications. All the guidelines were classified as low quality, since none scored ≥ 60% in at least three domains, including the Rigour of Development. The median overall rate was 3 (IQR 1), the highest score was 4.5, 27 and the lowest was 2. 38, [41] [42] [43] Association between AGREE II score and characteristics of the CPG Updated CPGs scored significantly higher in the AGREE II overall rate. CPGs developed in Europe showed significantly higher scores in the domains Scope and purpose, Stakeholder involvement and Clarity of presentation. However, we did not find significant differences between guidelines developed by Ministries or government agencies and scientific societies. (Table 3) . A high significant correlation between the scores of AGREE II domains and the overall rate was observed, except for Editorial Independence (r=0.374; p=0.078) (Appendix S2). This study showed a low quality for CPGs developed during the first eight months of the pandemic aimed at minimizing the risk of contagion by COVID-19 during dental care. The domain with the highest score was Scope and Purpose (median 67.0%), and the one with the lowest score was Editorial Independence (median 8.0%). According to the AGREE II instrument the median overall rate was 3.0 (IQR 1.0). Only one of the CPGs was recommended with modifications by the reviewers. Although the domains 'Scope and purpose' and 'Clarity of presentation' obtained a mean quality score of over 60%, remaining domains presented an exceptionally poor report reflected in very low scores. The low score for the remaining domains, was also reported for other guidelines carried out in the context of the COVID-19 pandemic. 46 to perform external peer reviews, and incomplete information with regard to development methods. 48 Similarly, these aspects were also observed in our study. In our research, only two guidelines 27,28 presented a score higher than 60% in at least three domains. Notwithstanding the above, whether performed during or outside a pandemic context, 46, 47, 49 the quality of the CPGs in the dental field in general tend to be of substandard quality with AGREE II overall rate. The 'Stakeholder involvement' domain presented a low-quality score, namely as a result of poor information with regard to group participants developing the guide and the information related to the target population. This was also observed among guidelines developed during the COVID-19 47 pandemic and outbreaks of other diseases. 50 In a pandemic context, where the rapid development of recommendations is needed, it is difficult to meet some of the aspects in this domain. A contributing factor to the lower quality, may be that participation of all the relevant stakeholders is often not feasible. 51 The domain "Rigour of Development" is usually considered the main domain of evaluation in clinical guidelines, since it assesses the process used to gather and synthesize the evidence and methods to formulate the recommendations. 19 In our research, we pointed out that the guidelines developed in the initial months of the COVID-19 pandemic, presented a poor report, with little information regarding the methods used for the synthesis of the evidence, or for the development of the recommendations. Very few CPGs related the recommendations to the supporting evidence. Furthermore, they did not report conducting external peer reviews prior to publication. This is also consistent with guidelines developed in response to health emergencies for both disease outbreaks, 48, 50 and guidelines developed in times of the COVID-19 pandemic. 46, 47, 52 It is possible that the low score in "Rigour of Development" presented in the guidelines developed during the initial period of the COVID-19 pandemic, was related to the difficulty in obtaining reliable evidence, since very little information of the virus was available. Hence, studies currently available have important methodological limitations. 53 For this reason, it is preferable to state that systematic reviews were not used in the process, because none were available in the period in which the guideline was developed, rather than to directly omit the information. 50 Due to the COVID-19 health emergency, some medical CPGs carried out in the first months of the pandemic based their recommendations in studies developed during the SARS outbreak in 2003. 54 Even though, the use of indirect evidence based on other viral infections is controversial, 55 it must be determined a priori which indirect evidence will be considered for the development of the CPG. 56 For example, the World Health Organization (WHO) developed recommendations for its COVID-19 guidelines based on a previously developed guideline for MERS, given that both are betacoronaviruses. 49 We consider that some of the recommendations made in the dental guidelines CPGs should incorporate the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach, since this provides a structured approach to determine the certainty of the evidence, and to make recommendations and decisions. 57 In our study, none of the guidelines used the GRADE approach to assess certainty of the evidence or to develop the recommendations, as reported in studies that evaluated COVID- The 'Applicability' domain also rendered a very low-quality score in our analysis, since the guidelines did not adequately report the facilitators and obstacles to its application. This was also reported in the study by Song et al. 58 for other guidelines related with COVID-19. The low score was also reported for dental guidelines carried out outside the pandemic context. 49 Evidently, the report for this domain should be implemented generally in dental guidelines, not only for those carried out during times of health emergencies. In this research, 'Editorial Independence' was the one domain that presented the lowest quality, with a score of 0% in at least 10 guidelines. In medical guidelines carried out during the current COVID-19 pandemic, this domain also presented a low-quality score, with a score of 0% for most of these. 54, 58 In our study, the low score obtained for this domain was the result of incomplete reports due to conflicts of interest. This fact was also observed by Norris et al. 48 In reference to the variables that influence the quality of the guidelines, our analysis showed that the CPGs produced in Europe had higher average scores compared to guidelines developed in other continents. Mubeen et al., 49 The main strengths of this study are that the information regarding development process of CPGs was obtained in a systematic search of the literature that included websites of developers and repositories of CPG. In addition, the guidelines were evaluated independently by two calibrated reviewers using a standardized tool. The AGREE II instrument is currently the only validated and reliable instrument that enables a quantitative comparison of CPGs, and is designed to help users to evaluate their methodological quality. However, there are certain limitations in our study. Even though, an extensive search including gray literature was carried out, it is possible that relevant guidelines in a language other than English, Spanish or Portuguese were not included. Furthermore, we only evaluated the latest version available, and some information reported in previous versions may provide additional information to those reported in the latest version, not being reflected in our evaluation. However, we think that this is unlikely as typically updated versions tend to show higher scores, as our results showed. Finally, the instrument used for quality evaluation (AGREE II) was not developed to evaluate CPGs for periods when timely and prompt answers are needed. 48 Some domains require longer time for their development impacting the level of quality. Developing trustworthy guidelines in a relatively short timeframe is a challenge, which has been evidenced in this study. Some domains that require more time to develop, will always be susceptible to lower quality. 50 However, guideline developers should establish methods to ensure the guideline is conducted in a transparent and evidence-based manner. Therefore, it is critical that developers are transparent and forthcoming about the difficulties that have arisen during the CPG development process. The low-quality of CPGs on dental services during the COVID-19 pandemic may not achieve effective health outcomes, or might not appropriately consider the risks of using those recommendations in a specific scenario. 19 This makes their implementation difficult for clinicians and policy makers, 59 and may interfere with patient adherence to the recommendations. 60 Future research should be aimed at optimizing the development process of the CPGs and allow updating recommendations as soon as relevant evidence becomes available. While some efforts have been made, 61 there is still uncertainty about the thresholds for changing recommendations or the potential approaches for their prompt publication and dissemination. In addition, efforts should be made to avoid duplication in the development of guidelines. Evidence ecosystem models attempt to address this issue, 61 however, there is a need for a comprehensive organization to guide and support all those involved Finally, it is imperative that COVID-19 dental guidelines use a transparent framework for rating the body of evidence, so that users can understand the mechanism used to develop the recommendations. The overall quality of CPGs on dental services provision during the first months of the COVID-19 pandemic was low, which makes its implementation difficult for clinicians and policy makers. Therefore, it is critical that developers are transparent and forthcoming about the difficulties that have arisen during the CPG development process. Table 1 . General information of the clinical practice guidelines. WHO statement regarding cluster of pneumonia cases in Wuhan World Health Organization (WHO) World Health Organization. Coronavirus disease 2019 (COVID-19): situation Report 51 Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis Risk assessment and management of exposure of health care workers in the context of COVID-19: Interim Guidance COVID-19 risk factors among health workers: a rapid review Transmission routes of 2019-nCoV and controls in dental practice Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Coronavirus disease 19 (COVID-19): implications for clinical dental care Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine COVID-19 transmission in dental practice: brief review of preventive measures in Italy Guidelines for dental care provision during the COVID-19 pandemic Pay for performance through the lens of medical professionalism Clinical Practice Guidelines We Can Trust. National Academy of Sciences The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration Systematic quality assessment of clinical practice guidelines to minimize the risk of Covid-19 transmission during dental care AGREE II: Advancing guideline development, reporting and evaluation in health care Nutrition in critically ill adults: A systematic quality assessment of clinical practice guidelines Dental caries prevention in children and adolescents: a systematic quality assessment of clinical practice guidelines The measurement of observer agreement for categorical data Correlation coefficients: Appropriate use and interpretation Released 2020. IBM SPSS Statistics for Mac Nota técnica GVIMS/GGTES/ANVISA No 04/2020. Orientações para serviços de saúde: medidas de prevenção e controle que devem ser adotadas durante a asistencia aos casos suspeitos ou confirmados de infeccção pelo novo coronavírus Ministry of Health Dental Council. Guidelines for oral health services at COVID-19 Ordem dos Médicos Dentistas, Programa nacional de Promoção da Saude Oral COVID-19: Procedimentos em clínicas, consultórios ou serviços de saúde oral dos cuidados de saúde primários Plan estratégico de acción para el periodo de desescalada COVID-19 The Scottish Dental Clinical Effectiveness Programme. Resuming General Dental Services Following COVID-19 Shutdown. A guide and implementation tools for general dental practice for Phase 2 of dental services remobilisation General-Dental-Services-Following-COVID-19-Shutdown-Update-120620.pdf College of General Dentistry, Faculty of General Dental Practice. Implications of COVID-19 for the safe management of general dental practice Protocolo de bioseguridad odontológica con énfasis en COVID-19 Center for Disease Control and Prevention. Guidance for Dental Settings. Interim Infection Prevention and Control Lineamiento técnico para la prevención y contención de COVID-19 para odontólogos y personal auxiliar de Costa Rica Orientaciones para atención odontológica en fase IV COVID-19 The College of Dental Surgeons of Saskatchewan. CDSS Alert -COVID-19 Pandemic: IPC Interim Protocol Update "RE -OPEN SASKATCHEWAN" -A Summary for Dentists COVID-19 guidance and standard operating procedure: For the provision of urgent dental care in primary care dental settings Standard operating procedure. Transition to recovery. A phased transition for dental practices towards the resumption of the full range of dental provision Consejo Mexicano de Rehabilitación Oral y Maxilofacial a.c., AMP, APP, Universidad de Concepción, Centro de Rehabilitación Oral Avanzada e Implantología-Facultad de Odontología. Manual de buenas prácticas en bioseguridad para ambientes odontológicos Ruta de atención para procedimientos de Odontología pediátrica durante la etapa de confinamiento o cuarentena de la pandemia COVID-19 Protocolo para atención Odontológica durante la pandemia de SARS-CoV-2 en la República del Paraguay Orientação de biossegurança. Adequações técnicas em tempos de COVID-19 Canadian Dental Association. Return to practice office manual COVID-19. Recomendaciones para Odontología Coronavírus COVID-19: Recomendações ao atendimento odontológico no SUS em A statutory body constituted under the dentists act Protocolo para atención odontológica en emergencias y urgencias odontológicas durante la emergencia sanitaria por COVID-19 American Dental Association. Return to Work Interim Guidance Toolkit Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: Rapid review Quality assessment of clinical practice guidelines for the management of paediatric dental emergencies applicable to the COVID-19 pandemic, using the AGREE II instrument. A systematic review An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaks Assessing the quality of dental clinical practice guidelines Development of rapid guidelines: 1. Systematic survey of current practices and methods Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations Anesthesia guidelines for COVID-19 patients: a narrative review and appraisal Waste in covid-19 research Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient Developing guidelines before, during and after the COVID-19 pandemic Developing trustworthy recommendations as part of an urgent response (1-2 weeks): a GRADE concept paper Using GRADE in situations of emergencies and urgencies: certainty in evidence and recommendations matters during the COVID-19 pandemic, now more than ever and no matter what Quality guidelines for corona virus disease 2019 with AGREE II instrument Healthcare providers' adherence to breast cancer guidelines in Europe: a systematic literature review Clinical Practice Guidelines: A Primer on development and dissemination Future of evidence ecosystem series: evidence ecosystems and learning health systems: why bother?